CRMD
CorMedix Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +7.1% ·
aandelenstroom +12.2% ·
netto nieuwe posities +6.7%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 33.01K | $241,641 | n/a | n/a |
| Q2 2026 | 82 | +2 | 27.12M | $212.84M | +4 | −4 |
| Q1 2026 | 85 | -1 | 25.38M | $172.62M | +10 | −11 |
| Q4 2025 | 85 | +1 | 28.40M | $330.32M | +1 | n/a |
| Q3 2025 | 16 | -2 | 20.70M | $240.74M | +1 | −3 |
| Q2 2025 | 15 | +1 | 18.26M | $224.97M | +2 | −1 |
| Q1 2025 | 11 | 0 | 6.59M | $40.58M | +1 | −1 |
| Q4 2024 | 11 | +1 | 7.02M | $56.86M | +2 | −1 |
| Q3 2024 | 9 | -2 | 3.76M | $30.38M | n/a | −2 |
| Q2 2024 | 11 | n/a | 4.01M | $17.37M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 5.36M | n/a | $66.03M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (passief) | 4.33M | n/a | $53.29M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Marshall Wace ✦ | 2.58M | +1019.2% | $31.79M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 4 | Citadel Advisors ✦ | 1.71M | +1517.6% | $21.12M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passief) | 1.60M | +4.1% | $19.73M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 1.60M | +11.4% | $19.67M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 316.96K | +1034.0% | $3.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 219.80K | -4.7% | $2.71M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 171.12K | +4.4% | $2.11M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 10 | Renaissance Technologies ✦ | 152.20K | Nieuw | $1.88M | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 98.67K | +582.0% | $1.22M | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 12 | Millennium Management ✦ | 56.29K | -84.8% | $693,444 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 32.11K | +20.3% | $396,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 28.04K | Nieuw | $345,443 | 0.0% | New | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 7.78K | n/a | $95,803 | 0.0% | n/c | 1 | SEC ↗ ×2 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Renaissance Technologies | $1.88M | 0.0% |
| Point72 Asset Management | $345,443 | 0.0% |
Verlaten
| Elliott Investment Management | $15.06M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 184 houders, 40.43M aandelen, $271.85M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.